2007
DOI: 10.1093/bja/ael321
|View full text |Cite
|
Sign up to set email alerts
|

Predictive performance of ‘Servin's formula’ during BIS®-guided propofol-remifentanil target-controlled infusion in morbidly obese patients

Abstract: Significant bias between predicted and measured plasma propofol concentrations was found while the low wobble values suggest that propofol TCI system is able to maintain stable drug concentrations over time. As already suggested before, a computer simulation confirmed that the TCI system performance could be significantly improved when total body weight is used.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
12
0
1

Year Published

2008
2008
2017
2017

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(15 citation statements)
references
References 35 publications
2
12
0
1
Order By: Relevance
“…The approved label for propofol indicates that dosing should be determined on a mg/kg total body weight (TBW) basis for all patients (17). However, caution is advised when dosing obese patients by this method as it may lead to higher than expected plasma concentrations and an increased risk of deleterious haemodynamic side effects (18)(19)(20)(21)(22)(23)(24). Additionally, anecdotal evidence from anesthetists suggests the current dosing label is unsuitable for the obese population as it results in deeper anesthesia and increased time to awakening (personal communication).…”
Section: Introductionmentioning
confidence: 99%
“…The approved label for propofol indicates that dosing should be determined on a mg/kg total body weight (TBW) basis for all patients (17). However, caution is advised when dosing obese patients by this method as it may lead to higher than expected plasma concentrations and an increased risk of deleterious haemodynamic side effects (18)(19)(20)(21)(22)(23)(24). Additionally, anecdotal evidence from anesthetists suggests the current dosing label is unsuitable for the obese population as it results in deeper anesthesia and increased time to awakening (personal communication).…”
Section: Introductionmentioning
confidence: 99%
“…We used CBW for the calculation of the dosage of propofol [27]. BIS may be used for the estimation of dosages of propofol in the morbidly obese [29]. In the obese the dosing of inhalation anaesthetics may be similar to dosing in non-obese patients, and may be based on the age of the patient [30,31].…”
Section: Discussionmentioning
confidence: 99%
“…Inicialmente el desempeño de los dispositivos TCI se consideró aceptable con MDPE% < ± 20% y MDAPE% del 20-40% 39 ; recientemente 40 se acepta como buen desempeño MDPE% < ± 15% y MDAPE% < 25%, condición que cumple el TCI sevoflurane © (tabla 3) [39][40][41][42][43] .…”
Section: Discussionunclassified